What are the treatment options for pruritus (itching)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Pruritus (Itching)

For generalized pruritus of unknown origin (GPUO), first-line treatment should include self-care advice, emollients, and topical therapies such as moderate-potency topical corticosteroids or menthol-containing preparations. 1

Initial Assessment and Treatment Algorithm

Step 1: Identify the Type of Pruritus

  • Inflammatory (e.g., eczema, psoriasis, dermatitis)
  • Neuropathic (e.g., postherpetic neuralgia)
  • Systemic disease-related (e.g., hepatic, renal, hematologic)
  • Drug-induced (e.g., opioid, chloroquine)
  • Unknown origin

Step 2: First-Line Topical Treatments

For All Types of Pruritus:

  • Emollients and moisturizers - Apply regularly to maintain skin barrier 1
  • Topical corticosteroids - For inflammatory causes:
    • Hydrocortisone 2.5% for mild cases 2, 3
    • Mometasone furoate 0.1% or betamethasone valerate 0.1% for moderate cases 1
    • Apply to affected areas up to 3-4 times daily 2

For Mild-to-Moderate Pruritus:

  • Menthol-containing preparations (0.5%) - Provides cooling sensation 1
  • Topical doxepin - Limited to 8 days, 10% of body surface area, and 12g daily 1

Step 3: Systemic Treatments

First-Line Systemic Options:

  • Non-sedating antihistamines for daytime use:
    • Loratadine 10mg daily
    • Fexofenadine 180mg daily 1

Second-Line Systemic Options:

  • Sedating antihistamines for nighttime use:
    • Hydroxyzine 25-50mg daily 1, 4
    • Cetirizine 10mg daily 1

For Refractory Cases:

  • Combination H1 and H2 antagonists (e.g., fexofenadine and cimetidine) 1
  • Antiepileptic agents:
    • Gabapentin (900-3600mg daily)
    • Pregabalin (25-150mg daily) 1, 3
  • Other agents based on specific causes:
    • Paroxetine, mirtazapine, or naltrexone for GPUO 1
    • Rifampicin as first-line for hepatic pruritus 1

Specific Treatment Approaches by Cause

For Inflammatory Pruritus (60% of cases) 3:

  • Topical anti-inflammatory therapies
  • Consider referral to dermatology for systemic treatments if topical therapies fail

For Neuropathic Pruritus (25% of cases) 3:

  • Topical agents: menthol, pramoxine, or lidocaine
  • Gabapentin or pregabalin
  • Referral to relevant specialist 1

For Drug-Induced Pruritus:

  • Opioid-induced: Naltrexone (first choice) or methylnaltrexone 1
  • Postoperative: Diclofenac 100mg rectally 1
  • Chloroquine-induced: Prednisolone 10mg, niacin 50mg, or combination 1

For Hepatic Pruritus:

  1. Rifampicin (first-line) 1
  2. Cholestyramine (second-line) 1
  3. Sertraline (third-line) 1
  4. Naltrexone or nalmefene (fourth-line) 1
  5. Consider other options for refractory cases 1

Important Caveats and Pitfalls

  • Avoid crotamiton cream for GPUO (Strength of recommendation B) 1
  • Avoid topical capsaicin or calamine lotion for GPUO 1
  • Do not use gabapentin in hepatic pruritus 1
  • Limit sedating antihistamines to short-term use except in palliative care, as long-term use may predispose to dementia 1
  • Recognize that antihistamines are most effective for histamine-mediated pruritus (e.g., urticaria) but may be less effective for other causes 5
  • Consider referral to secondary care if there is diagnostic doubt or if primary care management does not relieve symptoms 1

Remember that pruritus can significantly impact quality of life and may be a symptom of serious underlying disease. Treatment should address both symptom relief and the underlying cause when identified.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current topical and systemic therapies for itch.

Handbook of experimental pharmacology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.